← back to search

Phillip O. Coffin

University of California, San Francisco · US
Area of research
Epidemiology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Opioid Use Disorder Treatment, HIV, Drug Use, Sexual Risk, Substance Abuse Treatment and Outcomes, and Forensic Toxicology and Drug Analysis.
h-index
41
citations
6,170
works
212
NIH funding
primary concept
email

Recent publications

Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl
JAMA Network Open 2025cited by 26position: lastdoi
Overdose from Unintentional Fentanyl Use when Intending to Use a Non-opioid Substance: An Analysis of Medically Attended Opioid Overdose Events
Journal of Urban Health 2024cited by 27position: lastdoi
Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: a retrospective cohort study
Harm Reduction Journal 2024cited by 22position: middledoi
“They made me feel like I mattered”: a qualitative study of how mobile crisis teams can support people experiencing homelessness
BMC Public Health 2024cited by 13position: middledoi
Methamphetamine Toxicities and Clinical Management
NEJM Evidence 2023cited by 24position: firstdoi
“If you're strung out and female, they will take advantage of you”: A qualitative study exploring drug use and substance use service experiences among women in Boston and San Francisco
Journal of Substance Use and Addiction Treatment 2023cited by 12position: middledoi
Brief Report: The Role of Substance Use in Structural Heart Disease Among Women Living With HIV
JAIDS Journal of Acquired Immune Deficiency Syndromes 2023cited by 3position: middledoi
Emergency department visits and trends related to cocaine, psychostimulants, and opioids in the United States, 2008–2018
BMC Emergency Medicine 2022cited by 40position: lastdoi
Modeling of overdose and naloxone distribution in the setting of fentanyl compared to heroin
Drug and Alcohol Dependence 2022cited by 34position: firstdoi
A Chronic Condition Disguised as an Acute Event: the Case for Re-thinking Stimulant Overdose Death
Journal of General Internal Medicine 2022cited by 22position: lastdoi
“There’s No Heroin Around Anymore. It’s All Fentanyl.” Adaptation of an Opioid Overdose Prevention Counseling Approach to Address Fentanyl Overdose: Formative Study
JMIR Formative Research 2022cited by 16position: lastdoi
Drug Overdose Deaths Before and After Shelter-in-Place Orders During the COVID-19 Pandemic in San Francisco
JAMA Network Open 2021cited by 93position: middledoi
Using ICD-10-CM codes to detect illicit substance use: A comparison with retrospective self-report
Drug and Alcohol Dependence 2021cited by 48position: lastdoi
Illicit opioid use following changes in opioids prescribed for chronic non-cancer pain
PLoS ONE 2020cited by 72position: firstdoi
How simulation modeling can support the public health response to the opioid crisis in North America: Setting priorities and assessing value
International Journal of Drug Policy 2020cited by 12position: middledoi
Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men
JAMA Psychiatry 2019cited by 129position: firstdoi
Overdose Education and Naloxone Distribution in the San Francisco County Jail
Journal of Correctional Health Care 2019cited by 45position: middledoi
Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review
Preventive Medicine 2018cited by 66position: lastdoi
Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic
International Journal of Drug Policy 2017cited by 291position: middledoi
Performance Measures of Diagnostic Codes for Detecting Opioid Overdose in the Emergency Department
Academic Emergency Medicine 2016cited by 99position: lastdoi
Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths
Journal of Urban Health 2016cited by 82position: lastdoi
Opioid Overdose Deaths in the City and County of San Francisco: Prevalence, Distribution, and Disparities
Journal of Urban Health 2015cited by 110position: lastdoi
Predictors of participant engagement and naloxone utilization in a community‐based naloxone distribution program
Addiction 2015cited by 88position: lastdoi
Correlates of overdose risk perception among illicit opioid users
Drug and Alcohol Dependence 2015cited by 55position: lastdoi
Brief overdose education is sufficient for naloxone distribution to opioid users
Drug and Alcohol Dependence 2014cited by 97position: lastdoi
Police Officers’ and Paramedics’ Experiences with Overdose and Their Knowledge and Opinions of Washington State’s Drug Overdose–Naloxone–Good Samaritan Law
Journal of Urban Health 2013cited by 141position: middledoi
Dose-Response Associations Between Number and Frequency of Substance Use and High-Risk Sexual Behaviors Among HIV-Negative Substance-Using Men Who Have Sex With Men (SUMSM) in San Francisco
JAIDS Journal of Acquired Immune Deficiency Syndromes 2013cited by 78position: middledoi
Aripiprazole for the treatment of methamphetamine dependence: a randomized, double‐blind, placebo‐controlled trial
Addiction 2012cited by 65position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Glenn‐Milo Santos · University of California, San Francisco11 papers (2012–2021)Eric Vittinghoff · University of California, San Francisco8 papers (2012–2023)Christopher Rowe · University of California, Berkeley7 papers (2014–2021)Emily Behar · Universidade Federal da Paraíba4 papers (2014–2018) · 4 papers (2012–2022) · 4 papers (2014–2019)Leslie W. Suen · San Francisco General Hospital4 papers (2022–2025)Christine S. Soran · San Francisco General Hospital3 papers (2024–2025)Alexander Y. Walley · Boston University3 papers (2017–2023)Elise D. Riley · University of California, San Francisco3 papers (2022–2023)Peter J. Davidson · University of California System3 papers (2015–2019)Grant Colfax · San Francisco Department of Public Health3 papers (2012–2019)Hannah Snyder · George Washington University Hospital3 papers (2024–2025) · 2 papers (2024–2025)Alexander R. Bazazi · University of California, San Francisco2 papers (2024–2025)Vanessa McMahan · Harvard University2 papers (2022–2023)Janet J. Myers · University of California, San Francisco2 papers (2024–2025)Moupali Das · Gilead Sciences (United States)2 papers (2012–2013) · 2 papers (2018–2020) · 2 papers (2012–2019)